Asensus Surgical, Inc.
ASXC · AMEX
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $91,226 | $59,238 | $84,301 | $69,170 |
| - Cash | $7,782 | $6,995 | $17,096 | $21,669 |
| + Debt | $20,433 | $5,456 | $5,682 | $5,495 |
| Enterprise Value | $103,877 | $57,699 | $72,887 | $52,996 |
| Revenue | $2,207 | $1,123 | $5,431 | $1,089 |
| % Growth | 96.5% | -79.3% | 398.7% | – |
| Gross Profit | -$562 | -$2,047 | $1,053 | -$1,780 |
| % Margin | -25.5% | -182.3% | 19.4% | -163.5% |
| EBITDA | -$24,402 | -$17,199 | -$16,073 | -$17,394 |
| % Margin | -1,105.7% | -1,531.5% | -295.9% | -1,597.2% |
| Net Income | -$25,749 | -$22,497 | -$17,235 | -$18,318 |
| % Margin | -1,166.7% | -2,003.3% | -317.3% | -1,682.1% |
| EPS Diluted | -0.095 | -0.08 | -0.065 | -0.072 |
| % Growth | -18.3% | -22.7% | 8.8% | – |
| Operating Cash Flow | -$14,220 | -$14,008 | -$13,374 | -$15,049 |
| Capital Expenditures | -$111 | $0 | -$73 | -$322 |
| Free Cash Flow | -$14,331 | -$14,008 | -$13,447 | -$15,371 |